 | • レポートコード：MRC2012A7868 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組換えDNAワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。組換えDNAワクチンの種類別市場規模（組換えタンパク質ワクチン、遺伝子ワクチン）、用途別市場規模（人間、動物）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Plumbline Life Sciences、Zoties、GSK、Indian Immunologicals、Sanofi、Boehringer-Ingelheim、Elanco ・地域別グローバル市場分析 2015年-2020年 ・組換えDNAワクチンの北米市場（アメリカ、カナダ、メキシコ） ・組換えDNAワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・組換えDNAワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・組換えDNAワクチンの南米市場（ブラジル、アルゼンチン） ・組換えDNAワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：組換えタンパク質ワクチン、遺伝子ワクチン ・用途別分析：人間、動物 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Recombinant DNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Recombinant DNA Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Recombinant DNA Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant DNA Vaccine market has been segmented into
Recombinant Protein Vaccine
Gene-Based Vaccine
By Application, Recombinant DNA Vaccine has been segmented into:
Human
Animal
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant DNA Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant DNA Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant DNA Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant DNA Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant DNA Vaccine Market Share Analysis
Recombinant DNA Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant DNA Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant DNA Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant DNA Vaccine are:
Merck
Plumbline Life Sciences
Zoties
GSK
Indian Immunologicals
Sanofi
Boehringer-Ingelheim
Elanco
Among other players domestic and global, Recombinant DNA Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant DNA Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant DNA Vaccine, with price, sales, revenue and global market share of Recombinant DNA Vaccine in 2018 and 2019.
Chapter 3, the Recombinant DNA Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant DNA Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Recombinant DNA Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Recombinant DNA Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Recombinant DNA Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant DNA Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant DNA Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Human
1.3.3 Animal
1.4 Overview of Global Recombinant DNA Vaccine Market
1.4.1 Global Recombinant DNA Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Plumbline Life Sciences
2.2.1 Plumbline Life Sciences Details
2.2.2 Plumbline Life Sciences Major Business
2.2.3 Plumbline Life Sciences SWOT Analysis
2.2.4 Plumbline Life Sciences Product and Services
2.2.5 Plumbline Life Sciences Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Zoties
2.3.1 Zoties Details
2.3.2 Zoties Major Business
2.3.3 Zoties SWOT Analysis
2.3.4 Zoties Product and Services
2.3.5 Zoties Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Indian Immunologicals
2.5.1 Indian Immunologicals Details
2.5.2 Indian Immunologicals Major Business
2.5.3 Indian Immunologicals SWOT Analysis
2.5.4 Indian Immunologicals Product and Services
2.5.5 Indian Immunologicals Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Product and Services
2.6.4 Sanofi Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Boehringer-Ingelheim
2.7.1 Boehringer-Ingelheim Details
2.7.2 Boehringer-Ingelheim Major Business
2.7.3 Boehringer-Ingelheim Product and Services
2.7.4 Boehringer-Ingelheim Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Elanco
2.8.1 Elanco Details
2.8.2 Elanco Major Business
2.8.3 Elanco Product and Services
2.8.4 Elanco Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant DNA Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant DNA Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant DNA Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant DNA Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant DNA Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant DNA Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant DNA Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant DNA Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant DNA Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant DNA Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant DNA Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant DNA Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant DNA Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
6.4 France Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant DNA Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant DNA Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant DNA Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
7.5 India Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant DNA Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant DNA Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant DNA Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant DNA Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant DNA Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant DNA Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant DNA Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant DNA Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant DNA Vaccine Price by Type (2015-2020)
11 Global Recombinant DNA Vaccine Market Segment by Application
11.1 Global Recombinant DNA Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Recombinant DNA Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant DNA Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant DNA Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant DNA Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant DNA Vaccine Market Forecast (2021-2025)
12.2.2 Europe Recombinant DNA Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant DNA Vaccine Market Forecast (2021-2025)
12.2.4 South America Recombinant DNA Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant DNA Vaccine Market Forecast (2021-2025)
12.3 Recombinant DNA Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant DNA Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant DNA Vaccine Market Share Forecast by Type (2021-2025)
12.4 Recombinant DNA Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant DNA Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant DNA Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Recombinant DNA Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant DNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant DNA Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Recombinant DNA Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Recombinant DNA Vaccine Major Business
Table 10. Merck Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. Merck SWOT Analysis
Table 12. Merck Recombinant DNA Vaccine Product and Services
Table 13. Merck Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Plumbline Life Sciences Basic Information, Manufacturing Base and Competitors
Table 15. Plumbline Life Sciences Recombinant DNA Vaccine Major Business
Table 16. Plumbline Life Sciences Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Plumbline Life Sciences SWOT Analysis
Table 18. Plumbline Life Sciences Recombinant DNA Vaccine Product and Services
Table 19. Plumbline Life Sciences Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Zoties Basic Information, Manufacturing Base and Competitors
Table 21. Zoties Recombinant DNA Vaccine Major Business
Table 22. Zoties Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. Zoties SWOT Analysis
Table 24. Zoties Recombinant DNA Vaccine Product and Services
Table 25. Zoties Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. GSK Basic Information, Manufacturing Base and Competitors
Table 27. GSK Recombinant DNA Vaccine Major Business
Table 28. GSK Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 29. GSK SWOT Analysis
Table 30. GSK Recombinant DNA Vaccine Product and Services
Table 31. GSK Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 33. Indian Immunologicals Recombinant DNA Vaccine Major Business
Table 34. Indian Immunologicals Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 35. Indian Immunologicals SWOT Analysis
Table 36. Indian Immunologicals Recombinant DNA Vaccine Product and Services
Table 37. Indian Immunologicals Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Recombinant DNA Vaccine Major Business
Table 40. Sanofi Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 41. Sanofi SWOT Analysis
Table 42. Sanofi Recombinant DNA Vaccine Product and Services
Table 43. Sanofi Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 45. Boehringer-Ingelheim Recombinant DNA Vaccine Major Business
Table 46. Boehringer-Ingelheim Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 47. Boehringer-Ingelheim SWOT Analysis
Table 48. Boehringer-Ingelheim Recombinant DNA Vaccine Product and Services
Table 49. Boehringer-Ingelheim Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Elanco Basic Information, Manufacturing Base and Competitors
Table 51. Elanco Recombinant DNA Vaccine Major Business
Table 52. Elanco Recombinant DNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 53. Elanco SWOT Analysis
Table 54. Elanco Recombinant DNA Vaccine Product and Services
Table 55. Elanco Recombinant DNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Recombinant DNA Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 57. Global Recombinant DNA Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Recombinant DNA Vaccine Sales by Regions (2015-2020) (K Units)
Table 59. Global Recombinant DNA Vaccine Sales Market Share by Regions (2015-2020)
Table 60. Global Recombinant DNA Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Recombinant DNA Vaccine Sales by Countries (2015-2020) (K Units)
Table 62. North America Recombinant DNA Vaccine Sales Market Share by Countries (2015-2020)
Table 63. North America Recombinant DNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Recombinant DNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 65. Europe Recombinant DNA Vaccine Sales by Countries (2015-2020) (K Units)
Table 66. Europe Recombinant DNA Vaccine Sales Market Share by Countries (2015-2020)
Table 67. Europe Recombinant DNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Recombinant DNA Vaccine Sales by Regions (2015-2020) (K Units)
Table 69. Asia-Pacific Recombinant DNA Vaccine Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Recombinant DNA Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Recombinant DNA Vaccine Sales by Countries (2015-2020) (K Units)
Table 72. South America Recombinant DNA Vaccine Sales Market Share by Countries (2015-2020)
Table 73. South America Recombinant DNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Recombinant DNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Recombinant DNA Vaccine Sales by Countries (2015-2020) (K Units)
Table 76. Middle East & Africa Recombinant DNA Vaccine Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Recombinant DNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Recombinant DNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 79. Global Recombinant DNA Vaccine Sales by Type (2015-2020) (K Units)
Table 80. Global Recombinant DNA Vaccine Sales Share by Type (2015-2020)
Table 81. Global Recombinant DNA Vaccine Revenue by Type (2015-2020) (USD Million)
Table 82. Global Recombinant DNA Vaccine Revenue Share by Type (2015-2020)
Table 83. Global Recombinant DNA Vaccine Sales by Application (2015-2020) (K Units)
Table 84. Global Recombinant DNA Vaccine Sales Share by Application (2015-2020)
Table 85. Global Recombinant DNA Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 86. Global Recombinant DNA Vaccine Market Share Forecast by Regions (2021-2025)
Table 87. Global Recombinant DNA Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 88. Global Recombinant DNA Vaccine Market Share Forecast by Type (2021-2025)
Table 89. Global Recombinant DNA Vaccine Sales Forecast by Application (2021-2025)
Table 90. Global Recombinant DNA Vaccine Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant DNA Vaccine Picture
Figure 2. Global Sales Market Share of Recombinant DNA Vaccine by Type in 2019
Figure 3. Recombinant Protein Vaccine Picture
Figure 4. Gene-Based Vaccine Picture
Figure 5. Recombinant DNA Vaccine Sales Market Share by Application in 2019
Figure 6. Human Picture
Figure 7. Animal Picture
Figure 8. Global Recombinant DNA Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Recombinant DNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Recombinant DNA Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Recombinant DNA Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Recombinant DNA Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Recombinant DNA Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Recombinant DNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Recombinant DNA Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Recombinant DNA Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Recombinant DNA Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Recombinant DNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Recombinant DNA Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Recombinant DNA Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Recombinant DNA Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Recombinant DNA Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Recombinant DNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Recombinant DNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Recombinant DNA Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Recombinant DNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Recombinant DNA Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Recombinant DNA Vaccine Revenue Market Share by Regions 2019
Figure 61. China Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Recombinant DNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Recombinant DNA Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Recombinant DNA Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Recombinant DNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Recombinant DNA Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Recombinant DNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Recombinant DNA Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Recombinant DNA Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Recombinant DNA Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Recombinant DNA Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Recombinant DNA Vaccine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Recombinant DNA Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Recombinant DNA Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Recombinant DNA Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Recombinant DNA Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
帯状疱疹ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Zoster Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Zoster Vaccine market report p…- 組換えヒトアルブミンの世界市場（～2026年） Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent. Market Analysis and Insights: Global Recombinant Human Albumin Market The global Recombinant Human Albumin ma…
- 組換えDNA技術の世界市場（～2026年） Market Analysis and Insights: Global Recombinant DNA Technology Market The global Recombinant DNA Technology market size is projected to reach US$ 511.5 million by 2026, from US$ 490.8 million in 2020, at a CAGR of 3.9%% during 2021-2026. Global Recombinant DNA Technology Scope and Market Size Recom…
- 組換えタンパク質の世界市場（～2026年） Market Analysis and Insights: Global Recombinant Protein Market The global Recombinant Protein market size is projected to reach US$ 665.5 million by 2026, from US$ 612 million in 2020, at a CAGR of 8.1%% during 2021-2026. Global Recombinant Protein Scope and Market Size Recombinant Protein market i…
- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …